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Abstract 
We report a case of a neonate born with a giant fibroma occupying the entirety of her left 
ventricle.  Due to the extensive resection, her postoperative course was complicated by 
severely diminished left ventricular function and complete heart block necessitating 
extracorporeal support.  Ultimately, cardiac resynchronization therapy was employed, after 
which the infant’s ventricular function gradually improved and she was successfully discharged 
to home. 
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Cardiac fibroma is the second most common primary cardiac tumor in the pediatric population 
[1]. Most commonly, cardiac fibromas are single, firm, non-encapsulated tumors involving the 
left ventricle (LV) free wall or septum [2]. Management will vary depending on age, weight, and 
tumor size and location.  Complete resection, if feasible, is the preferred approach, but partial 
resection, heart transplantation, or conservative management have also been applied.  We 
describe a neonate with a massive tumor in her left ventricle (LV) who, due to the extensive 
resection required, suffered unavoidable and unusual complications that necessitated a 
relatively novel management strategy that ultimately resulted in a successful discharge to home. 
 
 
The patient is a female neonate prenatally diagnosed with a massive cardiac tumor occupying 
her LV.  She was born at 38 weeks gestation via planned Caesarian section without 
complication.  Echocardiogram postnatally revealed a massive LV tumor and consequent LV 
outflow obstruction.  A prostaglandin E1 infusion was initiated immediately after birth to maintain 
ductal patency.  Cardiac MRI confirmed a large, well circumscribed mass occupying the LV 
without evidence of perfusion (Figure 1).  Cardiac catheterization demonstrated coronary 
compression of left anterior descending artery. 
 
At 4 days of life, she was taken to the operating room for surgical resection.(Figure 2 – artist 
sketch) Upon direct examination, a poorly vascularized mass burrowing through the LV was 
observed. A thin layer of epicardium and myocardium that was overlying the mass was 
dissected.  Upon reaching the inferior border, a space between the myocardium and tumor was 
created and the myocardium was dissected away from the tumor mass until much of the tumor 
was unroofed.(Figure 3)  The tumor base was then dissected away from the septum and the 
tumor was resected. Frozen biopsy revealed a benign fibroma.   
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Following resection, a ventricular septal defect (VSD) remained and the left anterior descending 
coronary artery was “free-floating” until it attached to the distal third of the LV.  The thinned-out 
ventricular septum was closed and the inner half of the myocardium was approximated, both of 
which were accomplished using running sutures. The epicardium and superficial half of the LV 
myocardium were then sutured in a simple continuous running fashion, taken from the base of 
the heart down towards the apex.  At this point, the LV was reconstructed to the extent possible. 
 
Postoperative transesophageal echocardiogram (TEE) showed marginal LV function and a 
small 2-mm residual VSD.  Also, complete atrioventricular block was present, for which 
temporary atrial and ventricular pacing wires were placed.  Due to these unavoidable sequelae 
of the extensive resection, she failed to wean from cardiopulmonary bypass.  She was placed 
on extracorporeal membrane oxygenation (ECMO) via central cannulation and transferred to the 
cardiovascular intensive care unit.  
 
On postoperative day 2, TEE showed slightly improved LV function with good motion of the 
posterior wall and apex, but with a hypokinetic and thin-walled outlet septum.  More concerning, 
the size of the residual VSD appeared larger than previously noted, with considerable left-to-
right shunting. On the following day, a 5.5-mm pulmonary artery (PA) band was placed at 
bedside.  Over the ensuing several days, LV function appeared to be improving but RV function 
was diminished, deemed to be related to the PA band.  Consequently, the PA band was 
removed and on postoperative day 7, the VSD was closed with a Dacron patch.  After this 
intervention, the patient tolerated weaning from ECMO support over the next 24 hours.  Five 
days later, to address her persistent complete atrioventricular block, a Medtronic pacemaker 
pulse generator and new epicardial electrodes were surgically placed. 
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Over the next several weeks, despite the initial encouraging improvement, she continued to 
require mechanical ventilation and vasoactive support.  Serial echocardiograms demonstrated 
persistent depressed LV function with paradoxical septal motion, due in large part to her paced 
rhythm and extensive septal patch.   Further, the patient’s size and the extensive ventricular 
septal reconstruction raised concerns regarding the effectiveness of a ventricular assist device.  
After a thorough discussion with family and the multidisciplinary team, the consensus was to 
continue ventilator and vasoactive support and list her for heart transplantation.    
 
Unfortunately, she remained on mechanical ventilation for many weeks awaiting heart 
transplantation.   As the risks associated with prolonged mechanical ventilation mounted, the 
team decided to attempt cardiac resynchronization therapy (CRT) as a means of improving her 
cardiac function and facilitate extubation.  On postoperative day 96, she underwent implantation 
of a biventricular permanent pacemaker.  Intraoperatively, her previous left upper abdominal 
quadrant pacemaker site was reopened and her pacemaker was temporarily explanted.  The 
site that corresponded to the apex of the heart was then exposed and a Medtronic epicardial 
surface lead (model 4965-25) was sutured to this site. The leads were then secured to a 
Medtronic biventricular permanent pacemaker (Viva CRT-P, model C6TR01) and the device 
was implanted into a subcutaneous pocket.  DDD pacing was initiated, with a lower rate of 130 
beats per minute and upper tracking rate of 180 beats per minute. 
 
Over the next few weeks, cardiac function gradually improved.  On postoperative day 124, she 
was successfully extubated from mechanical ventilation.  She was then slowly transitioned from 
intravenous vasoactive medications to an oral congestive heart failure regimen and, on 
postoperative day 179, was discharge home.  At 16 months of age, she remains stable as an 
outpatient with her native heart, steadily gaining weight and progressing developmentally.     
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Comment 
Cardiac fibromas are benign tumors which are typically solitary, circumscribed, firm, non-
encapsulated and, in many cases, calcified centrally [3]. Cardiac fibromas can intertwine with 
the ventricular muscle and detrimentally affect cardiac function by replacing functional cardiac 
mass. A newborn infant with a LV fibroma can present with left-sided heart failure and mimic 
ductal dependent systemic blood flow lesions, while right-sided tumors can present with severe 
cyanosis and right heart failure, mimicking ductal dependent pulmonary blood flow lesions [3]. In 
older pediatric patients, symptoms can present from incidental findings in an otherwise healthy 
patient to congestive heart failure, life-threatening arrhythmias, and sudden cardiac death.  
 
Though complete resection is preferred, alternative management approaches include use of the 
Damus-Kaye-Stanzel procedure, a modified Norwood procedure with partial tumor resection, 
heart transplantation, or temporary single ventricle palliation as a bridge to transplantation [4,5].  
In our patient, complete resection of the mass was chosen, considering the near complete 
obliteration of her LV cavity, obstruction of left LV outflow, and less than ideal long-term 
morbidity associated with single ventricle palliation.  Unfortunately, the postoperative course 
was complicated by an unavoidable ventricular septal defect and complete atrioventricular 
block.  Consequent severely hypokinetic ventricular septum and less than optimal 
atrioventricular synchrony resulting from univentricular pacing then lead to chronic refractory 
heart failure and dependence on invasive mechanical ventilation. 
 
CRT is an established treatment in adults with heart failure, but efficacy and indication in 
children is less clear [6].   The outcome of CRT in a neonate with poor LV function and 
ventricular dysynchrony resulting from the resection of a massive LV tumor was likewise 
unclear.  Fortunately, CRT lead to significant improvement in her cardiac function and 
successful discharge to home.      
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Figure Legends 
Figure 1.  MRI reveals a large, well circumscribed, non-vascularized left ventricular mass 
measuring 4.2 cm X 4.1 cm X 3.8 cm. 
 
Figure 2: Two layers closure of left ventriculotomy with endocardial alignment of papillary 
muscles to provide mitral support and competent.   
 
Figure 3:  The left ventricle, which consisted of a thin layer of epicardium and myocardium, was 
dissected and a space between the myocardium and tumor was created, allowing access into 
the LV cavity.  
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